$1.50
0.67% yesterday
Nasdaq, Jun 11, 10:00 pm CET
ISIN
US81749D1072
Symbol
SERA

Sera Prognostics Inc - Ordinary Shares Class A Stock price

$1.50
-0.82 35.34% 1M
-7.26 82.88% 6M
-6.64 81.57% YTD
-6.83 81.99% 1Y
-10.40 87.40% 5Y
-10.40 87.40% 10Y
-10.40 87.40% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
+0.01 0.67%
ISIN
US81749D1072
Symbol
SERA
Sector

Key metrics

Market capitalization $56.51m
Enterprise Value $10.39m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 86.58
P/S ratio (TTM) P/S ratio 470.91
P/B ratio (TTM) P/B ratio 0.60
Revenue growth (TTM) Revenue growth -40.00%
Revenue (TTM) Revenue $120.00k
EBIT (operating result TTM) EBIT $-36.78m
Free Cash Flow (TTM) Free Cash Flow $-26.93m
Cash position $46.20m
EPS (TTM) EPS $-0.78
P/E forward negative
P/S forward 161.46
EV/Sales forward 29.69
Short interest 3.41%
Show more

Is Sera Prognostics Inc - Ordinary Shares Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,836 stocks worldwide.

Sera Prognostics Inc - Ordinary Shares Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Sera Prognostics Inc - Ordinary Shares Class A forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Sera Prognostics Inc - Ordinary Shares Class A forecast:

Buy
67%
Hold
33%

Financial data from Sera Prognostics Inc - Ordinary Shares Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
0.12 0.12
40% 40%
100%
- Direct Costs 0.10 0.10
38% 38%
83%
0.01 0.01
75% 75%
8%
- Selling and Administrative Expenses 22 22
2% 2%
18,683%
- Research and Development Expense 14 14
3% 3%
11,983%
-36 -36
2% 2%
-29,950%
- Depreciation and Amortization 0.84 0.84
3% 3%
700%
EBIT (Operating Income) EBIT -37 -37
2% 2%
-30,650%
Net Profit -33 -33
2% 2%
-27,492%

In millions USD.

Don't miss a Thing! We will send you all news about Sera Prognostics Inc - Ordinary Shares Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sera Prognostics Inc - Ordinary Shares Class A Stock News

Neutral
PRNewsWire
14 days ago
SALT LAKE CITY , May 29, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that members of the Sera team will participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conferen...
Neutral
PRNewsWire
29 days ago
SALT LAKE CITY , May 14, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, from 9:30 – 9:55 a.m. ET. Zhenya Lindgardt, ...
Neutral
Seeking Alpha
about one month ago
Sera Prognostics Inc (NASDAQ:SERA ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Zhenya Lindgardt - President, CEO & Director Austin Aerts - CFO Conference Call Participants Dan Brennan - TD Cowen. Operator Good afternoon and welcome to the Sera Prognostics Conference Call to review First Quarter Fiscal Year 2025 Results.
More Sera Prognostics Inc - Ordinary Shares Class A News

Company Profile

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Evguenia Lindgardt
Employees 56
Founded 2008
Website www.seraprognostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today